Rockwell Medical, Inc.
RMTI
$1.10
-$0.03-2.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 101.49M | 98.92M | 94.37M | 86.62M | 83.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 101.49M | 98.92M | 94.37M | 86.62M | 83.61M |
| Cost of Revenue | 84.01M | 82.19M | 81.69M | 77.45M | 74.91M |
| Gross Profit | 17.48M | 16.72M | 12.69M | 9.17M | 8.70M |
| SG&A Expenses | 16.86M | 15.96M | 15.10M | 14.89M | 14.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 100.88M | 98.34M | 97.47M | 93.19M | 90.28M |
| Operating Income | 608.00K | 580.00K | -3.09M | -6.57M | -6.67M |
| Income Before Tax | -480.00K | -1.24M | -4.77M | -8.42M | -8.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.48 | -1.24 | -4.77 | -8.42 | -8.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -480.00K | -1.24M | -4.77M | -8.42M | -8.44M |
| EBIT | 608.00K | 580.00K | -3.09M | -6.57M | -6.67M |
| EBITDA | 2.79M | 2.77M | -885.00K | -4.74M | -5.23M |
| EPS Basic | -0.04 | -0.06 | -0.18 | -0.38 | -0.46 |
| Normalized Basic EPS | -0.01 | -0.03 | -0.11 | -0.24 | -0.29 |
| EPS Diluted | -0.04 | -0.07 | -0.18 | -0.39 | -0.47 |
| Normalized Diluted EPS | -0.01 | -0.03 | -0.11 | -0.24 | -0.29 |
| Average Basic Shares Outstanding | 124.21M | 119.98M | 115.95M | 102.30M | 85.52M |
| Average Diluted Shares Outstanding | 126.66M | 122.43M | 117.53M | 102.30M | 85.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |